1. “Herd immunity”: a rough guide.;Fine;Clin Infect Dis,2011
2. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2.;Voysey;Lancet,2021
3. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA.;Loomba;Nat Hum Behav,2021
4. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.;Saad-Roy;Science,2020
5. Johnson & Johnson announces single-shot Janssen COVID-19 vaccine candidate met primary endpoints in interim analysis of its phase 3 ENSEMBLE trial. January 29, 2021. Accessed February 10, 2021. https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial